| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-13 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |